Becton, Dickinson and Company (BDX)

233,83 -0,53 (-0,23%) Al cierre: 04:00PM EDT

Becton, Dickinson and Company

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
201 847 6800
https://www.bd.com

Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 73.000

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Thomas E. Polen Jr.	President, CEO & Chairman	3,46M	N/A	1973
Mr. Christopher J. DelOrefice	Executive VP & CFO	1,6M	N/A	1972
Ms. Shana Carol Neal	Executive VP & Chief People Officer	1,79M	N/A	1966
Mr. David B. Hickey	Executive VP & President of Life Sciences Segment	1,11M	562,03k	1964
Mr. Michael Garrison	Executive VP & President of Medical segment	1,73M	N/A	1970
Mr. Thomas J. Spoerel	Senior VP, Controller & Chief Accounting Officer	N/A	N/A	1979
Ms. Elizabeth McCombs	Executive VP & Chief Technology Officer	N/A	N/A	1976
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.	Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board	N/A	N/A	N/A
Ms. Denise Russell Fleming	Executive VP of Technology & Global Services and Chief Information Officer	N/A	N/A	1970
Mr. Greg Rodetis	Head of Investor Relations	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Gobierno corporativo

El ISS Governance QualityScore de Becton, Dickinson and Company, a día 1 de abril de 2024, es 10. Las puntuaciones base son Auditoría: 10; Tablero: 8; Derechos de los accionistas: 9; Compensación: 10.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.